Stock FOLD AMICUS THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Revisions Amicus Therapeutics, Inc.

Equities

FOLD

US03152W1099

Real-time Estimate Cboe BZX
Other stock markets
 09:35:28 2024-04-19 am EDT 		5-day change 1st Jan Change
10.36 USD +0.24% Intraday chart for Amicus Therapeutics, Inc. -7.93% -27.20%
Mar. 18 JPMorgan Adjusts Price Target on Amicus Therapeutics to $19 From $21, Maintains Overweight Rating MT
Mar. 05 Amicus Therapeutics Insider Sold Shares Worth $389,543, According to a Recent SEC Filing MT

Turnover - Change in analysts' estimates

Earnings Per Share (EPS) - Change in analysts' estimates

EBIT - Change in analysts' estimates

Dividend / Share (DPS) - Change in analysts' estimates

Cash or Net Debt - Change in analysts' estimates

Turnover

Earnings Per Share (EPS)

EBIT

Dividend / Share (DPS)

Cash or Net Debt

  1. Stock Market
  2. Equities
  3. FOLD Stock
  4. Revisions Amicus Therapeutics, Inc.